Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Sep 11;99(37):e22173. doi: 10.1097/MD.0000000000022173

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc.

This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0

PMC Copyright notice

Immunostaining for AGGF1 (angiogenic factor with G-patch and FHA domain 1), FOXC2 (forkhead box C2), and E-cad (E-cadherin) in esophageal squamous cell carcinoma and control tissue. A, Positive AGGF1 in the cytoplasm of esophageal squamous cell carcinoma tissue (40 magnification) B, Positive AGGF1 in the cytoplasm of esophageal squamous cell carcinoma tissue (40 magnification); C, Negative AGGF1 in the control tissue (100 magnification), C: Negative AGGF1 in the control tissue; D, Positive FOXC2 in the cytoplasm of cancer cells (40 magnification); E, Positive FOXC2 in the cytoplasm of cancer cells (400 magnification); F, Negative FOXC2 in the control tissues (100 magnification); G, Positive E-cad in the cytoplasm and membrane of cancer tissue (40 magnification), H, Positive E-cad in the cytoplasm and membrane of cancer tissue (400 magnification); I, Positive E-cad in the cytoplasm and membrane of control cells (400 magnification).